Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kindbody is a fertility clinic network and family-building benefits provider for employers.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Oruka Therapeutics received $700.4M in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $26.6B.
Perceptive Advisors's average investment size is $135.1M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include Kindbody, Acrivon Therapeutics, Forte Biosciences, Merida Biosciences, Opus Genetics(formerly Ocuphire Pharma). These companies were founded in 2020 or later.